At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide [PMID: 38055301] Laboratory literature summary: At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide
"We have something just as good" from an unfamiliar manufacturer should be a red flag
[27] [28] Patients should nonetheless report any unexpected changes in mood, alertness, or symptom control to their prescriber, as individual responses can vary
1) revealed substitutions at the known DPP-4 cleavage site (Ala 8 in human) to Ser or Phe in platypus and echidna respectively, predicting that DPP-4 cleavage could be affected
A: The optimal time is after meals, as per the recommended dosage, to facilitate effective absorption and maximize health benefits